John Sampson, MD - Publications

Affiliations: 
2014- Neurosurgery Duke University, Durham, NC 

260 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Michael SW, Siddall AG, O'Leary TJ, Groeller H, Sampson JA, Blacker SD, Drain JR. Monitoring Work and Training Load in Military Settings - What's in the Toolbox? European Journal of Sport Science. 1-18. PMID 34463198 DOI: 10.1080/17461391.2021.1971774  1
2021 Toro C, Temkin N, Barber J, Manley G, Jain S, Ohnuma T, Komisarow J, Foreman B, Korley FK, Vavilala MS, Laskowitz DT, Mathew JP, Hernandez A, Sampson J, James ML, et al. Association of Vasopressor Choice with Clinical and Functional Outcomes Following Moderate to Severe Traumatic Brain Injury: A TRACK-TBI Study. Neurocritical Care. PMID 34341913 DOI: 10.1007/s12028-021-01280-7  1
2021 Mohan AA, Tomaszewski WH, Haskell-Mendoza AP, Hotchkiss KM, Singh K, Reedy JL, Fecci PE, Sampson JH, Khasraw M. Targeting Immunometabolism in Glioblastoma. Frontiers in Oncology. 11: 696402. PMID 34222022 DOI: 10.3389/fonc.2021.696402  1
2021 McKay BA, Delaney JA, Simpkin A, Larkin T, Murray A, Pedlar C, Lewis NA, Sampson JA. The Association Between Alterations in Redox Homeostasis, Cortisol, and Commonly Used Objective and Subjective Markers of Fatigue in American Collegiate Football. International Journal of Sports Physiology and Performance. 1-7. PMID 34051699 DOI: 10.1123/ijspp.2020-0933  1
2021 Krishnamoorthy V, Temkin N, Barber J, Foreman B, Komisarow J, Korley FK, Laskowitz DT, Mathew JP, Hernandez A, Sampson J, James ML, Bartz R, Raghunathan K, Goldstein BA, Markowitz AJ, et al. Association of Early Multiple Organ Dysfunction With Clinical and Functional Outcomes Over the Year Following Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study. Critical Care Medicine. PMID 33935162 DOI: 10.1097/CCM.0000000000005055  1
2021 Ellingson BM, Sampson JH, Achrol AS, Aghi MK, Krystof Bankiewicz K, Wang C, Bexon M, Brem S, Brenner AJ, Chowdhary S, Floyd JR, Han SJ, Kesari S, Randazzo D, Vogelbaum MA, et al. Modified RANO (mRANO), iRANO, and standard RANO response to convection-enhanced delivery of IL4R-targeted immunotoxin MDNA55 in recurrent glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33863808 DOI: 10.1158/1078-0432.CCR-21-0446  1
2021 Tomobi O, Toy S, Ondari M, Lee S, Nelson-Williams H, Koroma M, Sampson JB. Evaluating Rapid-cycle Deliberate Practice Versus Mastery Learning in Training Nurse Anesthetists on the Universal Anaesthesia Machine Ventilator in Sierra Leone. The Journal of Education in Perioperative Medicine : Jepm. 23: E658. PMID 33778103 DOI: 10.46374/volxxiii_issue1_sampson  1
2021 Swartz AM, Congdon KL, Nair SK, Li QJ, Herndon JE, Suryadevara CM, Riccione KA, Archer GE, Norberg PK, Sanchez-Perez LA, Sampson JH. A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope. Npj Vaccines. 6: 12. PMID 33462231 DOI: 10.1038/s41541-020-00273-5  1
2021 Luu D, Komisarow J, Mills BM, Vavilala MS, Laskowitz DT, Mathew J, James ML, Hernandez A, Sampson J, Fuller M, Ohnuma T, Raghunathan K, Privratsky J, Bartz R, Krishnamoorthy V. Association of Severe Acute Kidney Injury with Mortality and Healthcare Utilization Following Isolated Traumatic Brain Injury. Neurocritical Care. PMID 33442812 DOI: 10.1007/s12028-020-01183-z  1
2021 Gromeier M, Brown MC, Zhang G, Lin X, Chen Y, Wei Z, Beaubier N, Yan H, He Y, Desjardins A, Herndon JE, Varn FS, Verhaak RG, Zhao J, Bolognesi DP, ... Sampson JH, et al. Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy. Nature Communications. 12: 352. PMID 33441554 DOI: 10.1038/s41467-020-20469-6  1
2020 Whalan M, Lovell R, Thorborg K, Sampson JA. The 11+ of the future: a primary injury prevention framework for sub-elite football. British Journal of Sports Medicine. PMID 33060157 DOI: 10.1136/bjsports-2020-102788  1
2020 Brady M, Raghavan R, Sampson J. Determinants of Intraparenchymal Infusion Distributions: Modeling and Analyses of Human Glioblastoma Trials. Pharmaceutics. 12. PMID 32967184 DOI: 10.3390/Pharmaceutics12090895  1
2020 Gedeon PC, Champion CD, Rhodin KE, Woroniecka K, Kemeny HR, Bramall AN, Bernstock JD, Choi BD, Sampson JH. Checkpoint inhibitor immunotherapy for glioblastoma: current progress, challenges and future outlook. Expert Review of Clinical Pharmacology. PMID 32862726 DOI: 10.1080/17512433.2020.1817737  0.01
2020 Hotchkiss KM, Sampson JH. Temozolomide treatment outcomes and immunotherapy efficacy in brain tumor. Journal of Neuro-Oncology. PMID 32813186 DOI: 10.1007/s11060-020-03598-2  1
2020 Sampson JA, Venables S, Debeneditics T, Peoples GE. A pilot study using a small-sided games program to modify cardiovascular health in sedentary Indigenous men. Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals. PMID 32810344 DOI: 10.1002/hpja.409  0.01
2020 Gedeon PC, Streicker MA, Schaller TH, Archer GE, Jokinen MP, Sampson JH. GLP toxicology study of a fully-human T cell redirecting CD3:EGFRvIII binding immunotherapeutic bispecific antibody. Plos One. 15: e0236374. PMID 32735564 DOI: 10.1371/journal.pone.0236374  1
2020 Batich KA, Mitchell DA, Healy P, Herndon JE, Sampson JH. Once, Twice, Three Times a Finding: Reproducibility of Dendritic Cell Vaccine Trials Targeting Cytomegalovirus in Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32719000 DOI: 10.1158/1078-0432.CCR-20-1082  1
2020 Brown GA, Veith S, Sampson JA, Whalan M, Fullagar HHK. Influence of Training Schedules on Objective Measures of Sleep in Adolescent Academy Football Players. Journal of Strength and Conditioning Research. PMID 32639380 DOI: 10.1519/JSC.0000000000003724  1
2020 Evgin L, Huff AL, Wongthida P, Thompson J, Kottke T, Tonne J, Schuelke M, Ayasoufi K, Driscoll CB, Shim KG, Reynolds P, Monie DD, Johnson AJ, Coffey M, Young SL, ... ... Sampson J, et al. Oncolytic virus-derived type I interferon restricts CAR T cell therapy. Nature Communications. 11: 3187. PMID 32581235 DOI: 10.1038/S41467-020-17011-Z  1
2020 Khasraw M, Reardon DA, Weller M, Sampson JH. PD-1 inhibitors: Do they have a future in the treatment of glioblastoma? Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32527943 DOI: 10.1158/1078-0432.CCR-20-1135  1
2020 Wu Y, Kelly SH, Sanchez-Perez L, Sampson JH, Collier JH. Comparative study of α-helical and β-sheet self-assembled peptide nanofiber vaccine platforms: influence of integrated T-cell epitopes. Biomaterials Science. PMID 32452474 DOI: 10.1039/d0bm00521e  1
2020 Reardon DA, Brandes AA, Omuro A, Mulholland P, Lim M, Wick A, Baehring J, Ahluwalia MS, Roth P, Bähr O, Phuphanich S, Sepulveda JM, De Souza P, Sahebjam S, Carleton M, ... ... Sampson J, et al. Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial. Jama Oncology. PMID 32437507 DOI: 10.1001/Jamaoncol.2020.1024  1
2020 Burley SD, Drain JR, Sampson JA, Nindl BC, Groeller H. Effect of a novel low volume, high intensity concurrent training regimen on recruit fitness and resilience. Journal of Science and Medicine in Sport. PMID 32345543 DOI: 10.1016/j.jsams.2020.03.005  1
2020 Schaller TH, Snyder DJ, Spasojevic I, Gedeon PC, Sanchez-Perez L, Sampson JH. First in human dose calculation of a single-chain bispecific antibody targeting glioma using the MABEL approach. Journal For Immunotherapy of Cancer. 8. PMID 32273346 DOI: 10.1136/jitc-2019-000213  1
2020 Reardon DA, Desjardins A, Vredenburgh JJ, O'Rourke DM, Tran DD, Fink KL, Nabors LB, Li G, Bota DA, Lukas RV, Ashby LS, Duic JP, Mrugala MM, Cruickshank S, Vitale L, ... ... Sampson JH, et al. Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32034072 DOI: 10.1158/1078-0432.Ccr-18-1140  1
2020 Shen SH, Woroniecka K, Barbour AB, Fecci PE, Sanchez-Perez L, Sampson JH. Checkpoint inhibition and CAR T cells for the Treatment of Glioblastoma. Expert Opinion On Biological Therapy. PMID 32027536 DOI: 10.1080/14712598.2020.1727436  1
2020 Moravan MJ, Fecci PE, Anders CK, Clarke JM, Salama AKS, Adamson JD, Floyd SR, Torok JA, Salama JK, Sampson JH, Sperduto PW, Kirkpatrick JP. Current multidisciplinary management of brain metastases. Cancer. PMID 31971613 DOI: 10.1002/Cncr.32714  1
2019 Sampson JH, Gunn MD, Fecci PE, Ashley DM. Brain immunology and immunotherapy in brain tumours. Nature Reviews. Cancer. PMID 31806885 DOI: 10.1038/s41568-019-0224-7  1
2019 Weakley JJS, Read DB, Fullagar HHK, Ramirez-Lopez C, Jones B, Cummins C, Sampson JA. "How Am I Going, Coach?"-The Effect of Augmented Feedback During Small-Sided Games on Locomotor, Physiological, and Perceptual Responses. International Journal of Sports Physiology and Performance. 1-8. PMID 31715583 DOI: 10.1123/ijspp.2019-0078  1
2019 Huang MN, Nicholson LT, Batich KA, Swartz AM, Kopin D, Wellford S, Prabhakar VK, Woroniecka K, Nair SK, Fecci PE, Sampson JH, Gunn MD. Antigen-loaded monocyte administration induces potent therapeutic anti-tumor T cell responses. The Journal of Clinical Investigation. PMID 31661470 DOI: 10.1172/JCI128267  1
2019 Fecci PE, Sampson JH. The current state of immunotherapy for gliomas: an eye toward the future. Journal of Neurosurgery. 131: 657-666. PMID 31473668 DOI: 10.3171/2019.5.JNS181762  1
2019 Whalan M, Lovell R, Steele JR, Sampson JA. Rescheduling Part 2 of the 11+ reduces injury burden and increases compliance in semi-professional football. Scandinavian Journal of Medicine & Science in Sports. PMID 31376194 DOI: 10.1111/sms.13532  1
2019 Schaller TH, Foster MW, Thompson JW, Spasojevic I, Normantaite D, Moseley MA, Sanchez-Perez L, Sampson JH. Pharmacokinetic analysis of a novel human EGFRvIII:CD3 bispecific antibody in plasma and whole blood using a high-resolution targeted mass spectrometry approach. Journal of Proteome Research. PMID 31267741 DOI: 10.1021/acs.jproteome.9b00145  1
2019 Fecci PE, Champion CD, Hoj J, McKernan C, Goodwin CR, Kirkpatrick J, Anders CK, Pendergast AM, Sampson JH. The Evolving Modern Management of Brain Metastasis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31213459 DOI: 10.1158/1078-0432.Ccr-18-1624  1
2019 Aldape K, Brindle KM, Chesler L, Chopra R, Gajjar A, Gilbert MR, Gottardo N, Gutmann DH, Hargrave D, Holland EC, Jones DTW, Joyce JA, Kearns P, Kieran MW, Mellinghoff IK, ... ... Sampson JH, et al. Reply to 'Assembling the brain trust: the multidisciplinary imperative in neuro-oncology'. Nature Reviews. Clinical Oncology. PMID 31150022 DOI: 10.1038/S41571-019-0236-Y  1
2019 Sampson JB, Lee BH, Koka R, Chima AM, Jackson EV, Ogbuagu OO, Tran TP, Rosen MA. Human Factors Evaluation of the Universal Anaesthesia Machine: Assessing Equipment with High-Fidelity Simulation Prior to Deployment in a Resource-Constrained Environment. Journal of the National Medical Association. PMID 31078287 DOI: 10.1016/J.Jnma.2019.03.005  1
2019 Orhurhu V, Olusunmade M, Urits I, Viswanath O, Peck J, Orhurhu MS, Adekoya P, Hirji S, Sampson J, Simopoulos T, Gill J. Trends of opioid use disorder amongst hospitalized patients with chronic pain. Pain Practice : the Official Journal of World Institute of Pain. PMID 31077526 DOI: 10.1111/papr.12789  0.01
2019 Desjardins A, Herndon JE, McSherry F, Ravelo A, Lipp ES, Healy P, Peters KB, Sampson JH, Randazzo D, Sommer N, Friedman AH, Friedman HS. Single-institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice. Health Science Reports. 2: e114. PMID 31049419 DOI: 10.1002/hsr2.114  1
2019 Hansen LJ, Sun R, Yang R, Singh SX, Chen LH, Pirozzi CJ, Moure CJ, Hemphill C, Carpenter AB, Healy P, Ruger RC, Chen CJ, Greer PK, Zhao F, Spasojevic I, ... ... Sampson JH, et al. MTAP loss promotes stemness in glioblastoma and confers unique susceptibility to purine starvation. Cancer Research. PMID 31040154 DOI: 10.1158/0008-5472.Can-18-1010  1
2019 Chang MP, Walters CB, Tsai C, Aksamit D, Kateh F, Sampson J. Evaluation of a Neonatal Resuscitation Curriculum in Liberia. Children (Basel, Switzerland). 6. PMID 30965659 DOI: 10.3390/children6040056  1
2019 Weakley J, Till K, Sampson J, Banyard H, Leduc C, Wilson K, Roe G, Jones B. The Effects of Augmented Feedback on Sprint, Jump, and Strength Adaptations in Rugby Union Players Following a Four Week Training Programme. International Journal of Sports Physiology and Performance. 1-21. PMID 30840517 DOI: 10.1123/ijspp.2018-0523  1
2019 Tomaszewski W, Sanchez-Perez L, Gajewski TF, Sampson JH. Brain Tumor Micro-environment and Host State - Implications for Immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30804019 DOI: 10.1158/1078-0432.Ccr-18-1627  1
2019 Sampson JA, Murray A, Williams S, Sullivan A, Fullagar HHK. Subjective Wellness, Acute: Chronic Workloads, and Injury Risk in College Football. Journal of Strength and Conditioning Research. PMID 30747901 DOI: 10.1519/JSC.0000000000003000  1
2019 Aldape K, Brindle KM, Chesler L, Chopra R, Gajjar A, Gilbert MR, Gottardo N, Gutmann DH, Hargrave D, Holland EC, Jones DTW, Joyce JA, Kearns P, Kieran MW, Mellinghoff IK, ... ... Sampson JH, et al. Challenges to curing primary brain tumours. Nature Reviews. Clinical Oncology. PMID 30733593 DOI: 10.1038/S41571-019-0177-5  1
2019 Chongsathidkiet P, Jackson C, Koyama S, Loebel F, Cui X, Farber SH, Woroniecka K, Elsamadicy AA, Dechant CA, Kemeny HR, Sanchez-Perez L, Cheema TA, Souders NC, Herndon JE, Coumans JV, ... Sampson JH, et al. Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors. Nature Medicine. PMID 30670876 DOI: 10.1038/s41591-019-0355-0  1
2019 Evgin L, Huff AL, Wongthida P, Thompson J, Kottke T, Sampson J, Perez LS, Vile R. Abstract A029: Unexpected antagonism between oncolytic virus derived type I interferon and EGFRvIII CAR T-cells Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-A029  1
2019 Landi D, Archer G, Driscoll T, Herndon J, Sampson J, Ashley D. Pdct-10. Feasibility Of Leukapheresis For Harvesting Monocytes And Generating Autologous Dendritic Cell Vaccines In Children With Malignant Brain Tumors Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.772  1
2019 Schaller T, Foster M, Spasojevic I, Gedeon P, Sanchez-Perez L, Sampson J. EXTH-09. FIRST-IN-HUMAN DOSING CONSIDERATIONS OF A BISPECIFIC ANTIBODY FOR TREATING GLIOBLASTOMA Neuro-Oncology. 21: vi84-vi84. DOI: 10.1093/Neuonc/Noz175.343  0.01
2019 Weller M, Reardon D, Brandes A, Sampson J, Mulholland P, Wick A, Baehring J, Ahluwalia M, Roth P, Bähr O, Phuphanich S, Sepulveda J, Souza Pd, Sahebjam S, Potter V, et al. Atim-47. Nivolumab Vs Bevacizumab In Patients With Recurrent Glioblastoma: Exploratory Analysis Of Mgmt Methylation Status And Baseline Corticosteroid Use Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.045  1
2019 Peters K, Congdon K, Archer G, Woodring S, Jaggers D, Lipp E, Healy P, Herndon J, Soher B, Vlahovic G, Johnson M, Randazzo D, Desjardins A, Friedman H, Friedman A, ... Sampson J, et al. ATIM-31. SAFETY OF TUMOR-SPECIFIC PEPTIDE VACCINE TARGETING ISOCITRATE DEHYDROGENASE 1 MUTATION IN RECURRENT RESECTABLE LOW GRADE GLIOMA PATIENTS Neuro-Oncology. 21: vi8-vi8. DOI: 10.1093/Neuonc/Noz175.030  0.01
2019 Sampson J, Achrol AS, Aghi M, Bankiewicz K, Brem S, Brenner A, Butowski N, Chandhasin C, Chowdhary S, Coello M, Floyd JR, Kesari S, Merchant F, Merchant N, Randazzo D, et al. Atim-30. Combating Recurrent Glioblastoma With Mdna55, An Interleukin-4 Receptor Targeted Immunotherapy, Through Mri-Guided Convective Delivery Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.029  1
2019 Gromeier M, Brown M, Beuabier N, Yan H, He Y, Zhang G, Desjardins A, Herndon J, Bolognesi D, Friedman A, Friedman H, McSherry F, Lin X, Wei Z, Nair S, ... Sampson J, et al. ATIM-27. TUMOR MUTATIONAL BURDEN PREDICTS RESPONSE TO ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) IN MALIGNANT GLIOMA PATIENTS: ASSESSMENT OF TRANSCRIPTIONAL AND IMMUNOLOGICAL CORRELATES Neuro-Oncology. 21: vi7-vi7. DOI: 10.1093/Neuonc/Noz175.026  0.01
2019 Desjardins A, Randazzo D, Chandramohan V, Peters K, Johnson M, Threatt S, Bullock C, Jackman J, Healy P, Lipp E, Sampson J, Friedman A, Friedman H, Ashley D, Bigner D. ATIM-24. DOSE FINDING AND DOSE EXPANSION TRIAL OF D2C7 IMMUNOTOXIN (D2C7-IT) ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMA (MG) Neuro-Oncology. 21: vi6-vi6. DOI: 10.1093/Neuonc/Noz175.023  0.04
2018 Congdon KL, Sanchez-Perez LA, Sampson JH. Effective Effectors: How T cells Access and Infiltrate the Central nervous System. Pharmacology & Therapeutics. PMID 30557632 DOI: 10.1016/J.Pharmthera.2018.12.007  1
2018 Riccione KA, He LZ, Fecci PE, Norberg PK, Suryadevara CM, Swartz A, Healy P, Reap E, Keler T, Li QJ, Congdon KL, Sanchez-Perez L, Sampson JH. CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response. Oncoimmunology. 7: e1502904. PMID 30524899 DOI: 10.1080/2162402X.2018.1502904  1
2018 Choi BD, Maus MV, June CH, Sampson JH. ----Immunotherapy for Glioblastoma: Adoptive T-cell Strategies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30446589 DOI: 10.1158/1078-0432.Ccr-18-1625  1
2018 Suryadevara CM, Desai R, Farber SH, Choi BD, Swartz AM, Shen SH, Gedeon PC, Snyder DJ, Herndon JE, Healy P, Reap EA, Archer GE, Fecci PE, Sampson JH, Sanchez-Perez L. Preventing Lck activation in CAR T cells confers Treg resistance but requires 4-1BB signaling for them to persist and treat solid tumors in non-lymphodepleted hosts. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30425092 DOI: 10.1158/1078-0432.CCR-18-1211  1
2018 Zha Y, Ariyo M, Olaniran O, Ariyo P, Lyon C, Kalu Q, Latif A, Edmond B, Sampson JB. Cardiopulmonary Resuscitation Capacity in Referral Hospitals in Nigeria: Understanding the Global Health Disparity in Resuscitation Medicine. Journal of the National Medical Association. 110: 407-413. PMID 30126569 DOI: 10.1016/j.jnma.2017.09.002  0.01
2018 Chongsathidkiet P, Jackson C, Koyama S, Loebel F, Cui X, Farber SH, Woroniecka K, Elsamadicy AA, Dechant CA, Kemeny HR, Sanchez-Perez L, Cheema TA, Souders NC, Herndon JE, Coumans JV, ... ... Sampson JH, et al. Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors. Nature Medicine. PMID 30104766 DOI: 10.1038/s41591-018-0135-2  1
2018 Burley SD, Drain JR, Sampson JA, Groeller H. Positive, limited and negative responders: The variability in physical fitness adaptation to basic military training. Journal of Science and Medicine in Sport. PMID 30057366 DOI: 10.1016/j.jsams.2018.06.018  1
2018 Atik AF, Suryadevara CM, Schweller RM, West JL, Healy P, Herndon Ii JE, Congdon KL, Sanchez-Perez L, McLendon RE, Archer GE, Fecci P, Sampson JH. Hyaluronic acid based low viscosity hydrogel as a novel carrier for Convection Enhanced Delivery of CAR T cells. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 30041899 DOI: 10.1016/J.Jocn.2018.06.005  1
2018 Desjardins A, Gromeier M, Herndon JE, Beaubier N, Bolognesi DP, Friedman AH, Friedman HS, McSherry F, Muscat AM, Nair S, Peters KB, Randazzo D, Sampson JH, Vlahovic G, Harrison WT, et al. Recurrent Glioblastoma Treated with Recombinant Poliovirus. The New England Journal of Medicine. PMID 29943666 DOI: 10.1056/Nejmoa1716435  1
2018 Whalan M, Lovell R, McCunn R, Sampson JA. The incidence and burden of time loss injury in Australian men's sub-elite football (soccer): A single season prospective cohort study. Journal of Science and Medicine in Sport. PMID 29884595 DOI: 10.1016/j.jsams.2018.05.024  1
2018 Suryadevara CM, Desai R, Abel ML, Riccione KA, Batich KA, Shen SH, Chongsathidkiet P, Gedeon PC, Elsamadicy AA, Snyder DJ, Herndon JE, Healy P, Archer GE, Choi BD, Fecci PE, ... Sampson JH, et al. Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma. Oncoimmunology. 7: e1434464. PMID 29872570 DOI: 10.1080/2162402X.2018.1434464  1
2018 Swartz AM, Reap E, Norberg P, Schmittling R, Janetzki S, Sanchez-Perez L, Sampson JH. A simple and enzyme-free method for processing infiltrating lymphocytes from small mouse tumors for ELISpot analysis. Journal of Immunological Methods. PMID 29859231 DOI: 10.1016/j.jim.2018.05.015  1
2018 Colman H, Westphal M, Sampson JH. Introduction. Update on adult neuro-oncology. Neurosurgical Focus. 44: E1. PMID 29852765 DOI: 10.3171/2018.3.FOCUS18149  0.01
2018 Lovell R, Whalan M, Marshall PW, Sampson JA, Siegler JC, Buchheit M. Scheduling of Eccentric Lower-limb Injury Prevention Exercises during the Soccer micro-cycle: Which day of the week? Scandinavian Journal of Medicine & Science in Sports. PMID 29797592 DOI: 10.1111/sms.13226  1
2018 McCunn R, Fünten KA, Whalan M, Sampson JA, Meyer T. Soccer Injury Movement Screen (SIMS) Composite Score Is Not Associated With Injury Among Semi-Professional Soccer Players. The Journal of Orthopaedic and Sports Physical Therapy. 1-29. PMID 29739304 DOI: 10.2519/jospt.2018.8037  1
2018 Gedeon PC, Schaller TH, Chitneni SK, Choi BD, Kuan CT, Suryadevara CM, Snyder DJ, Schmittling RJ, Szafranski SE, Cui X, Healy P, Herndon JE, McLendon RE, Keir ST, Archer GE, ... Sampson JH, et al. A rationally designed fully human EGFRvIII:CD3-targeted bispecific antibody redirects human T cells to treat patient-derived intracerebral malignant glioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29703821 DOI: 10.1158/1078-0432.Ccr-17-0126  1
2018 Chima AM, Koka R, Lee B, Tran T, Ogbuagu OU, Nelson-Williams H, Rosen M, Koroma M, Sampson JB. Medical Simulation as a Vital Adjunct to Identifying Clinical Life-Threatening Gaps in Austere Environments. Journal of the National Medical Association. 110: 117-123. PMID 29580444 DOI: 10.1016/J.Jnma.2017.12.003  1
2018 Batich K, Ashley D, Archer G, Sanchez-Perez L, Norberg P, Congdon K, Herndon J, McSherry F, Gemberling S, Hesler R, Jaggers D, Van R, Parker J, Peters K, Desjardins A, ... Sampson J, et al. RBTT-02. ENHANCING VACCINE RESPONSES WITH DOSE-INTENSIFIED TEMOZOLOMIDE IN GLIOBLASTOMA: INITIATION OF THE I-ATTAC TRIAL Neuro-Oncology. 20: vi234-vi234. DOI: 10.1093/Neuonc/Noy148.972  0.01
2018 Batich K, Sanchez-Perez L, Schaller T, Cui X, Xie W, Archer G, Norberg P, Snyder D, Congdon K, Sampson J. IMMU-23. ANTIGEN-SPECIFIC EFFECTOR MEMORY CD4+ T CELLS AND CCL3 POTENTIATE DENDRITIC CELL VACCINES AND ANTITUMOR IMMUNITY Neuro-Oncology. 20: vi126-vi126. DOI: 10.1093/Neuonc/Noy148.526  0.01
2018 Salgado M, Schaller T, Gedeon P, Snyder D, Archer G, Sanchez-Perez L, Sampson J. Ddis-02. Novel Bispecific Activator Of Macrophages For The Treatment Of Glioblastoma Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.281  1
2018 Desjardins A, Randazzo D, Chandramohan V, Peters K, Johnson M, Thomas L, Threatt S, Bullock C, Herndon J, Boulton S, Healy P, Lipp E, Sampson J, Friedman A, Friedman H, et al. ATIM-36. DOSE ESCALATION TRIAL OF D2C7 IMMUNOTOXIN (D2C7-IT) ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMA (MG) Neuro-Oncology. 20: vi9-vi9. DOI: 10.1093/Neuonc/Noy148.031  0.01
2018 Ashley D, Desjardins A, Gromeier M, Muscat A, Herndon J, Friedman A, Friedman H, McSherry F, Randazzo D, Peters K, Threatt S, Bullock C, Miller E, Boulton S, Lipp E, ... Sampson J, et al. ATIM-27. INTRATUMORAL ADMINISTRATION OF AN ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) IN MALIGNANT GLIOMA PATIENTS: ASSESSMENT OF MUTATIONAL RESPONSE CORRELATES Neuro-Oncology. 20: vi7-vi7. DOI: 10.1093/Neuonc/Noy148.022  0.01
2018 Achrol A, Bexon M, Bankiewicz K, Brenner AJ, Butowski N, Kesari S, Merchant F, Merchant R, Randazzo D, Vogelbaum M, Zabek M, Sampson J. Atim-05. Intratumoral Delivery Of Mdna55, An Interleukin-4 Receptor Targeted Immunotherapy, By Mri-Guided Convective Delivery For The Treatment Of Recurrent Glioblastoma Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.002  1
2018 Gururangan S, Grant G, Driscoll T, Archer G, Herndon J, Friedman H, Kurtzberg J, Bigner D, Sampson J, Mitchell D. IMMU-27. Re-MATCH PROTOCOL: PHASE I STUDY OF AUTOLOGOUS TUMOR SPECIFIC LYMPHOCYTE TRANSFER (ALT) + DC VACCINE (DCV) DURING RECOVERY FROM MYELOABLATIVE CHEMOTHERAPY (MAC) AND AUTOLOGOUS STEM CELL RESCUE (HDC + ASCR) OR NON-MYELOABLATIVE CHEMOTHERAPY (NMAC) IN PATIENTS WITH RECURRENT CENTRAL PNETs (r-PNET) Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.343  1
2018 Landi D, Thompson E, Herndon J, Sampson J, Ashley D. IMMU-23. CMV pp65 RNA-PULSED DENDRITIC CELL VACCINES FOR PEDIATRIC GLIOBLASTOMA AND MEDULLOBLASTOMA: A PHASE I TRIAL Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy059.339  1
2018 Schuelke M, Evgin L, Wongthida P, Thompson J, Kottke T, Sanchez-Perez L, Sampson J, Vile R. IMMU-12. T-CELL THERAPIES DEMONSTRATE EFFICACY WITHOUT TOXICITY IN IMMUNOCOMPETENT MODELS OF BRAINSTEM TUMORS Neuro-Oncology. 20: i101-i101. DOI: 10.1093/Neuonc/Noy059.328  0.01
2018 Bexon MF, Achrol A, Bankiewicz K, Brenner A, Butowski N, Kesari S, Merchant F, Merchant R, Randazzo D, Vogelbaum M, Zabek M, Sampson J. Understanding biological activity, tumor response and pseudoprogression in a phase-IIb study of MDNA55 in adults with recurrent or progressive glioblastoma (GB). Annals of Oncology. 29. DOI: 10.1093/Annonc/Mdy273.368  1
2017 Ewend MG, Friedman AH, Sampson JH. In Memoriam: Robert H. Wilkins, MD, 1934 to 2017. Neurosurgery. 81: 6-8. PMID 31895452 DOI: 10.1093/neuros/nyx283  1
2017 Wu Y, Norberg PK, Reap EA, Congdon KL, Fries CN, Kelly SH, Sampson JH, Conticello VP, Collier JH. A Supramolecular Vaccine Platform Based on α-Helical Peptide Nanofibers. Acs Biomaterials Science & Engineering. 3: 3128-3132. PMID 30740520 DOI: 10.1021/Acsbiomaterials.7B00561  1
2017 Elsamadicy AA, Sergesketter A, Sampson JH, Gottfried ON. Institutional Review of Mortality in 5434 Consecutive Neurosurgery Patients: Are We Improving? Neurosurgery. PMID 29300938 DOI: 10.1093/neuros/nyx603  1
2017 Burdon CA, Park J, Tagami K, Groeller H, Sampson JA. The Effect of Practice on Performance and Pacing Strategies During an Exercise Circuit Involving Load-Carriage. Journal of Strength and Conditioning Research. PMID 29239981 DOI: 10.1519/JSC.0000000000002349  1
2017 Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, ... Sampson JH, et al. Go, no-go decision making for phase 3 clinical trials: ACT IV revisited - Authors' reply. The Lancet. Oncology. 18: e709-e710. PMID 29208433 DOI: 10.1016/S1470-2045(17)30856-2  1
2017 Limon D, McSherry F, Herndon J, Sampson J, Fecci P, Adamson J, Wang Z, Yin FF, Floyd S, Kirkpatrick J, Kim GJ. Single fraction stereotactic radiosurgery for multiple brain metastases. Advances in Radiation Oncology. 2: 555-563. PMID 29204522 DOI: 10.1016/J.Adro.2017.09.002  1
2017 Chan Seay R, Koroma AP, Coleman J, Sampson J, Koroma L, Ugwa EA, Anderson J. Post-Ebola situational assessment of opportunities for capacity building at the national obstetrics and gynecology referral hospital in Sierra Leone. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. PMID 29094370 DOI: 10.1002/ijgo.12374  0.01
2017 Reap E, Suryadevara CM, Batich KA, Sanchez-Perez L, Archer GE, Schmittling RJ, Norberg PK, Herndon JE, Healy P, Congdon KL, Gedeon PC, Campbell OC, Swartz AM, Riccione KA, Yi JS, ... Sampson JH, et al. Dendritic cells enhance polyfunctionality of adoptively transferred T cells which target cytomegalovirus in glioblastoma. Cancer Research. PMID 29093005 DOI: 10.1158/0008-5472.Can-17-0469  1
2017 Sampson JH, Haglund MM, Friedman AH, Ewend MG. Obituary. Robert H. Wilkins, MD, 1934-2017. Journal of Neurosurgery. 1-2. PMID 29027856 DOI: 10.3171/2017.6.JNS171416  1
2017 Schaller TH, Batich KA, Suryadevara CM, Desai R, Sampson JH. Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3. Expert Review of Clinical Immunology. PMID 28965431 DOI: 10.1080/1744666X.2017.1384313  1
2017 Ewend MG, Friedman AH, Sampson JH. In Memoriam: Robert H. Wilkins, MD, 1934 to 2017. Neurosurgery. 81: 6-8. PMID 28873999 DOI: 10.1093/neuros/nyx283  1
2017 Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, ... Sampson JH, et al. Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. The Lancet. Oncology. PMID 28844499 DOI: 10.1016/S1470-2045(17)30517-X  1
2017 Sankey EW, Butler E, Sampson JH. Accuracy of Novel CT-guided Frameless Stereotactic Drilling and Catheter System in Human Cadavers. World Neurosurgery. PMID 28754645 DOI: 10.1016/j.wneu.2017.07.098  0.01
2017 Haider A, Scott JW, Gause CD, Meheš M, Hsiung G, Prelvukaj A, Yanocha D, Baumann LM, Ahmed F, Ahmed N, Anderson S, Angate H, Arfaa L, Asbun H, Ashengo T, ... ... Sampson J, et al. Erratum to: Development of a Unifying Target and Consensus Indicators for Global Surgical Systems Strengthening: Proposed by the Global Alliance for Surgery, Obstetric, Trauma, and Anaesthesia Care (The G4 Alliance). World Journal of Surgery. PMID 28642965 DOI: 10.1007/s00268-017-4067-7  1
2017 Sampson JH, Maus MV, June CH. Immunotherapy for Brain Tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017728089. PMID 28640704 DOI: 10.1200/Jco.2017.72.8089  1
2017 Haider A, Scott JW, Gause CD, Meheš M, Hsiung G, Prelvukaj A, Yanocha D, Baumann LM, Ahmed F, Ahmed N, Anderson S, Angate H, Arfaa L, Asbun H, Ashengo T, ... ... Sampson J, et al. Development of a Unifying Target and Consensus Indicators for Global Surgical Systems Strengthening: Proposed by the Global Alliance for Surgery, Obstetric, Trauma, and Anaesthesia Care (The G4 Alliance). World Journal of Surgery. PMID 28508237 DOI: 10.1007/S00268-017-4028-1  1
2017 Weller M, Roth P, Preusser M, Wick W, Reardon DA, Platten M, Sampson JH. Vaccine-based immunotherapeutic approaches to gliomas and beyond. Nature Reviews. Neurology. PMID 28497804 DOI: 10.1038/Nrneurol.2017.64  1
2017 Narloch JL, Farber SH, Sammons S, McSherry F, Herndon JE, Hoang JK, Yin FF, Sampson JH, Fecci PE, Blackwell KL, Kirkpatrick JP, Kim GJ. Biopsy of enlarging lesions after stereotactic radiosurgery for brain metastases frequently reveals radiation necrosis. Neuro-Oncology. PMID 28472527 DOI: 10.1093/Neuonc/Nox090  1
2017 Batich KA, Reap EA, Archer GE, Sanchez-Perez L, Nair SK, Schmittling RJ, Norberg P, Xie W, Herndon JE, Healy P, McLendon RE, Friedman AH, Friedman HS, Bigner D, Vlahovic G, ... Sampson JH, et al. Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 23: 1898-1909. PMID 28411277 DOI: 10.1158/1078-0432.Ccr-16-2057  1
2017 Reardon DA, Wen PY, Wucherpfennig KW, Sampson JH. Immunomodulation for glioblastoma. Current Opinion in Neurology. PMID 28368867 DOI: 10.1097/Wco.0000000000000451  1
2017 Elsamadicy AA, Chongsathidkiet P, Desai R, Woroniecka K, Farber SH, Fecci PE, Sampson JH. Prospect of rindopepimut in the treatment of glioblastoma. Expert Opinion On Biological Therapy. 17: 507-513. PMID 28274144 DOI: 10.1080/14712598.2017.1299705  1
2017 McCunn R, Fullagar HH, Williams S, Halseth TJ, Sampson JA, Murray A. Playing Experience and Position Influence Injury Risk Among NCAA Division I Collegiate Footballers. International Journal of Sports Physiology and Performance. 1-24. PMID 28253034 DOI: 10.1123/ijspp.2016-0803  1
2017 Sayour EJ, De Leon G, Pham C, Grippin A, Kemeny H, Chua J, Huang J, Sampson JH, Sanchez-Perez L, Flores C, Mitchell DA. Systemic activation of antigen-presenting cells via RNA-loaded nanoparticles. Oncoimmunology. 6: e1256527. PMID 28197373 DOI: 10.1080/2162402X.2016.1256527  1
2017 Tsai C, Walters CB, Sampson J, Kateh F, Chang MP. Pediatric Mortality in a Rural Tertiary Care Center in Liberia. Children (Basel, Switzerland). 4. PMID 28146099 DOI: 10.3390/children4020008  1
2017 Bankiewicz K, Achrol A, Aghi M, Bexon M, Brenner A, Butowski N, Elder B, Floyd J, Lonser R, Merchant F, Rosemina M, Patel TR, Randazzo D, Souweidane M, Vogelbaum M, ... Sampson J, et al. Atim-16. Mri-Guided Convective Delivery Of Mdna55, An Interleukin-4 Receptor Targeted Immunotherapy For The Treatment Of Recurrent Glioblastoma Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.111  1
2017 Reardon DA, Omuro A, Brandes AA, Rieger J, Wick A, Sepulveda J, Phuphanich S, Souza Pd, Ahluwalia MS, Lim M, Vlahovic G, Sampson J. OS10.3 Randomized Phase 3 Study Evaluating the Efficacy and Safety of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: CheckMate 143 Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox036.071  1
2017 Omuro A, Vlahovic G, Baehring J, Butowski N, Reardon D, Cloughesy T, Sahebjam S, Lim M, Zwirtes R, Sampson J. OS07.3 Nivolumab in Combination With Radiotherapy With or Without Temozolomide in Patients With Newly Diagnosed Glioblastoma: Updated Results From CheckMate 143 Neuro-Oncology. 19: iii13-iii13. DOI: 10.1093/Neuonc/Nox036.044  0.01
2017 Lim M, Omuro A, Vlahovic G, Reardon D, Sahebjam S, Cloughesy T, Baehring J, Butowski N, Potter V, Zwirtes R, Paliwal P, Carleton M, Sampson J, Brandes A. Nivolumab (nivo) in combination with radiotherapy (RT) ± temozolomide (TMZ): Updated safety results from CheckMate 143 in pts with methylated or unmethylated newly diagnosed glioblastoma (GBM) Annals of Oncology. 28: v109. DOI: 10.1093/Annonc/Mdx366  0.01
2017 Wang C, Sun W, Kirkpatrick JP, Sampson J, Chang Z, Yin FF. Assessment of Concurrent Stereotactic Radiosurgery and Bevacizumab Treatment of Recurrent Malignant Gliomas Using Multiparametric MRI Imaging and Radiomics Analysis International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.2367  1
2016 Farber SH, Elsamadicy AA, Atik F, Suryadevara CM, Chongsathidkiet P, Fecci PE, Sampson JH. The Safety of available immunotherapy for the treatment of glioblastoma. Expert Opinion On Drug Safety. PMID 27989218 DOI: 10.1080/14740338.2017.1273898  1
2016 Thompson EM, Gururangan S, Grant G, Mitchell D, Sampson JH. The clinical and financial impact of a pediatric surgical neuro-oncology clinical trial. Journal of Neuro-Oncology. PMID 27864705 DOI: 10.1007/S11060-016-2338-Z  1
2016 Suryadevara CM, Riccione KA, Sampson JH. Immunotherapy gone viral: Bortezomib and oHSV enhance antitumor NK cell activity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27521450 DOI: 10.1158/1078-0432.CCR-16-1666  1
2016 Schaller TH, Sampson JH. Advances and challenges: dendritic cell vaccination strategies for glioblastoma. Expert Review of Vaccines. PMID 27500911 DOI: 10.1080/14760584.2016.1218762  1
2016 Raghavan R, Brady ML, Sampson JH. Delivering therapy to target: improving the odds for successful drug development. Therapeutic Delivery. 7: 457-81. PMID 27403630 DOI: 10.4155/tde-2016-0016  1
2016 Suryadevara CM, Desai R, Farber SH, Gedeon PC, Swartz A, Snyder D, Herndon J, Healy P, Choi BD, Fecci PE, Sanchez-Perez L, Sampson JH. 369 Chimeric Antigen Receptors Deficient in Lck Signaling Require 4-1BB Costimulation to Expand in Vivo, Resist Regulatory T-Cell Suppression, and Treat Solid Tumors in Immune-Intact Hosts. Neurosurgery. 63: 209-210. PMID 27399566 DOI: 10.1227/01.neu.0000489857.70440.98  1
2016 Sampson JH. Advances in Immunotherapy: Abhijit Guha Award Presentation. Neurosurgery. 63: 85-7. PMID 27399370 DOI: 10.1227/NEU.0000000000001286  0.01
2016 Li F, Liu X, Sampson JH, Bigner DD, Li CY. Rapid reprogramming of primary human astrocytes into potent tumor initiating cells with defined genetic factors. Cancer Research. PMID 27364552 DOI: 10.1158/0008-5472.Can-16-0171  1
2016 Desai R, Suryadevara CM, Batich KA, Farber SH, Sanchez-Perez L, Sampson JH. Emerging immunotherapies for glioblastoma. Expert Opinion On Emerging Drugs. 21: 133-145. PMID 27223671 DOI: 10.1080/14728214.2016.1186643  1
2016 Koka R, Chima AM, Sampson JB, Jackson EV, Ogbuagu OO, Rosen MA, Koroma M, Tran TP, Marx MK, Lee BH. Anesthesia Practice and Perioperative Outcomes at 2 Tertiary Care Hospitals in Freetown, Sierra Leone. Anesthesia and Analgesia. PMID 27088997 DOI: 10.1213/Ane.0000000000001285  1
2016 Berger M, Nadler JW, Friedman A, McDonagh DL, Bennett ER, Cooter M, Qi W, Laskowitz DT, Ponnusamy V, Newman MF, Shaw LM, Warner DS, Mathew JP, James ML. The Effect of Propofol Versus Isoflurane Anesthesia on Human Cerebrospinal Fluid Markers of Alzheimer's Disease: Results of a Randomized Trial. Journal of Alzheimer's Disease : Jad. PMID 27079717 DOI: 10.3233/Jad-151190  1
2016 Batich KA, Swartz AM, Sampson JH. Preconditioning Vaccine Sites for mRNA-Transfected Dendritic Cell Therapy and Antitumor Efficacy. Methods in Molecular Biology (Clifton, N.J.). 1403: 819-38. PMID 27076169 DOI: 10.1007/978-1-4939-3387-7_47  1
2016 Hulin BT, Gabbett TJ, Caputi P, Lawson DW, Sampson JA. Low chronic workload and the acute:chronic workload ratio are more predictive of injury than between-match recovery time: a two-season prospective cohort study in elite rugby league players. British Journal of Sports Medicine. PMID 26851288 DOI: 10.1136/bjsports-2015-095364  1
2016 Saraswathula A, Reap EA, Choi BD, Schmittling RJ, Norberg PK, Sayour EJ, Herndon JE, Healy P, Congdon KL, Archer GE, Sanchez-Perez L, Sampson JH. Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy. Cancer Immunology, Immunotherapy : Cii. PMID 26759007 DOI: 10.1007/S00262-015-1784-3  1
2016 Desjardins A, Randazzo D, Chandramohan V, Sampson J, Peters K, Vlahovic G, Threatt S, Herndon J, Boulton S, Lally-Goss D, Healy P, Lipp E, Friedman A, Friedman H, Bigner D. ATIM-18. PHASE I DOSE ESCALATION STUDY OF D2C7-IT ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMA (MG) Neuro-Oncology. 18: vi21-vi22. DOI: 10.1093/Neuonc/Now212.083  0.04
2016 Omuro A, Vlahovic G, Baehring J, Butowski NA, Reardon DA, Cloughesy T, Sahebjam S, Lim M, Strauss L, Latek R, Zwirtes R, Paliwal P, Harbison C, Sampson J. ATIM-16. NIVOLUMAB COMBINED WITH RADIOTHERAPY WITH OR WITHOUT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: RESULTS FROM PHASE 1 SAFETY COHORTS IN CHECKMATE 143 Neuro-Oncology. 18: vi21-vi21. DOI: 10.1093/Neuonc/Now212.081  0.01
2016 Weller M, Butowski N, Tran D, Recht L, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust S, Iwamoto F, Drappatz J, O’Rourke D, Wong M, Finocchiaro G, Perry J, ... Sampson J, et al. ATIM-03. ACT IV: AN INTERNATIONAL, DOUBLE-BLIND, PHASE 3 TRIAL OF RINDOPEPIMUT IN NEWLY DIAGNOSED, EGFRvIII-EXPRESSING GLIOBLASTOMA Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.068  1
2015 Sampson JH. Alternating Electric Fields for the Treatment of Glioblastoma. Jama. 314: 2511-3. PMID 26670969 DOI: 10.1001/jama.2015.16701  1
2015 Chang MP, Lyon CB, Janiszewski D, Aksam D, Kateh F, Sampson J. Evaluation of a cardiopulmonary resuscitation curriculum in a low resource environment. International Journal of Medical Education. 6: 136-41. PMID 26547092 DOI: 10.5116/ijme.563a.5d85  1
2015 Okada H, Weller M, Huang R, Finocchiaro G, Gilbert MR, Wick W, Ellingson BM, Hashimoto N, Pollack IF, Brandes AA, Franceschi E, Herold-Mende C, Nayak L, Panigrahy A, Pope WB, ... Sampson JH, et al. Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. The Lancet. Oncology. 16: e534-42. PMID 26545842 DOI: 10.1016/S1470-2045(15)00088-1  1
2015 Sampson JH, Mitchell DA. Vaccination strategies for neuro-oncology. Neuro-Oncology. 17: vii15-vii25. PMID 26516221 DOI: 10.1093/neuonc/nov159  1
2015 Hulin BT, Gabbett TJ, Lawson DW, Caputi P, Sampson JA. The acute:chronic workload ratio predicts injury: high chronic workload may decrease injury risk in elite rugby league players. British Journal of Sports Medicine. PMID 26511006 DOI: 10.1136/bjsports-2015-094817  1
2015 Drain JR, Sampson JA, Billing DC, Burley SD, Linnane DM, Groeller H. The Effectiveness of Basic Military Training To Improve Functional Lifting Strength in New Recruits. Journal of Strength and Conditioning Research / National Strength & Conditioning Association. 29: S173-7. PMID 26506184 DOI: 10.1519/JSC.0000000000001072  1
2015 Groeller H, Burley S, Orchard P, Sampson JA, Billing DC, Linnane D. How Effective Is Initial Military-Specific Training in the Development of Physical Performance of Soldiers? Journal of Strength and Conditioning Research. 29: S158-62. PMID 26506181 DOI: 10.1519/JSC.0000000000001066  1
2015 Fullagar HH, Sampson JA, Mott BJ, Burdon CA, Taylor NA, Groeller H. Employment Standards for Australian Urban Firefighters: Part 4: Physical Aptitude Tests and Standards. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 57: 1092-7. PMID 26461864 DOI: 10.1097/JOM.0000000000000528  1
2015 Groeller H, Fullagar HH, Sampson JA, Mott BJ, Taylor NA. Employment Standards for Australian Urban Firefighters: Part 3: The Transition From Criterion Task to Test. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 57: 1083-91. PMID 26461863 DOI: 10.1097/JOM.0000000000000527  1
2015 Taylor NA, Fullagar HH, Sampson JA, Notley SR, Durley SD, Lee DS, Groeller H. Employment Standards for Australian Urban Firefighters: Part 2: The Physiological Demands and the Criterion Tasks. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 57: 1072-82. PMID 26461862 DOI: 10.1097/JOM.0000000000000526  1
2015 Taylor NA, Fullagar HH, Mott BJ, Sampson JA, Groeller H. Employment Standards for Australian Urban Firefighters: Part 1: The Essential, Physically Demanding Tasks. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 57: 1063-71. PMID 26461861 DOI: 10.1097/JOM.0000000000000525  1
2015 Pham CD, Flores C, Yang C, Pinheiro EM, Yearley JH, Sayour E, Pei Y, Moore C, McLendon RE, Huang J, Sampson JH, Wechsler-Reya RJ, Mitchell DA. Differential immune microenvironments and response to immune checkpoint blockade amongst molecular subtypes of murine medulloblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26405194 DOI: 10.1158/1078-0432.Ccr-15-0713  1
2015 Nair SK, Driscoll T, Boczkowski D, Schmittling R, Reynolds R, Johnson LA, Grant G, Fuchs H, Bigner DD, Sampson JH, Gururangan S, Mitchell DA. Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma. Journal of Neuro-Oncology. PMID 26311248 DOI: 10.1007/S11060-015-1890-2  1
2015 Preusser M, Lim M, Hafler DA, Reardon DA, Sampson JH. Prospects of immune checkpoint modulators in the treatment of glioblastoma. Nature Reviews. Neurology. 11: 504-14. PMID 26260659 DOI: 10.1038/Nrneurol.2015.139  1
2015 Babu R, Sampson JH. Editorial: Patient validation of retrospective data. Journal of Neurosurgery. 123: 969-71. PMID 26252462 DOI: 10.3171/2015.3.JNS142959  1
2015 Suryadevara CM, Gedeon PC, Sanchez-Perez L, Verla T, Alvarez-Breckenridge C, Choi BD, Fecci PE, Sampson JH. Are BiTEs the "missing link" in cancer therapy? Oncoimmunology. 4: e1008339. PMID 26155413 DOI: 10.1080/2162402X.2015.1008339  1
2015 Choi BD, Fecci PE, Sampson JH. Editorial: Not everything that matters can be measured and not everything that can be measured matters. Journal of Neurosurgery. 123: 543-4. PMID 26115465 DOI: 10.3171/2015.2.JNS142977  1
2015 Rosen MA, Chima AM, Sampson JB, Jackson EV, Koka R, Marx MK, Kamara TB, Ogbuagu OU, Lee BH. Engaging staff to improve quality and safety in an austere medical environment: a case-control study in two Sierra Leonean hospitals. International Journal For Quality in Health Care : Journal of the International Society For Quality in Health Care / Isqua. PMID 26060230 DOI: 10.1093/Intqhc/Mzv030  1
2015 Vlahovic G, Fecci PE, Reardon D, Sampson JH. Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma. Neuro-Oncology. 17: 1043-5. PMID 25964311 DOI: 10.1093/neuonc/nov071  1
2015 Flores C, Pham C, Snyder D, Yang S, Sanchez-Perez L, Sayour E, Cui X, Kemeny H, Friedman H, Bigner DD, Sampson J, Mitchell DA. Novel role of hematopoietic stem cells in immunologic rejection of malignant gliomas. Oncoimmunology. 4: e994374. PMID 25949916 DOI: 10.4161/2162402X.2014.994374  1
2015 Lin R, Sampson JH, Li QJ, Zhu B. miR-23a blockade enhances adoptive T cell transfer therapy by preserving immune-competence in the tumor microenvironment. Oncoimmunology. 4: e990803. PMID 25949909 DOI: 10.4161/2162402X.2014.990803  1
2015 Fecci PE, Babu R, Adamson DC, Sampson JH. Editorial: Turning fluorescence into black and white. Journal of Neurosurgery. 122: 1356-9. PMID 25839932 DOI: 10.3171/2014.10.JNS141788  1
2015 Mitchell DA, Batich KA, Gunn MD, Huang MN, Sanchez-Perez L, Nair SK, Congdon KL, Reap EA, Archer GE, Desjardins A, Friedman AH, Friedman HS, Herndon JE, Coan A, McLendon RE, ... Sampson JH, et al. Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients. Nature. 519: 366-9. PMID 25762141 DOI: 10.1038/Nature14320  1
2015 Riccione K, Suryadevara CM, Snyder D, Cui X, Sampson JH, Sanchez-Perez L. Generation of CAR T cells for adoptive therapy in the context of glioblastoma standard of care. Journal of Visualized Experiments : Jove. PMID 25741761 DOI: 10.3791/52397  1
2015 Suryadevara CM, Verla T, Sanchez-Perez L, Reap EA, Choi BD, Fecci PE, Sampson JH. Immunotherapy for malignant glioma. Surgical Neurology International. 6: S68-77. PMID 25722935 DOI: 10.4103/2152-7806.151341  1
2015 Vaughan E, Sesay F, Chima A, Mehes M, Lee B, Dordunoo D, Sitch A, de Wildt G, Kamara TB, Leigh B, Abdullah F, Sampson J. An assessment of surgical and anesthesia staff at 10 government hospitals in Sierra Leone. Jama Surgery. 150: 237-44. PMID 25607469 DOI: 10.1001/Jamasurg.2014.2246  1
2015 Brown KE, Chagoya G, Kwatra SG, Yen T, Keir ST, Cooter M, Hoadley KA, Rasheed A, Lipp ES, Mclendon R, Ali-Osman F, Bigner DD, Sampson JH, Kwatra MM. Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development. Journal of Neurochemistry. 133: 730-8. PMID 25598002 DOI: 10.1111/Jnc.13032  1
2015 Schuster J, Lai RK, Recht LD, Reardon DA, Paleologos NA, Groves MD, Mrugala MM, Jensen R, Baehring JM, Sloan A, Archer GE, Bigner DD, Cruickshank S, Green JA, Keler T, ... Sampson JH, et al. A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study. Neuro-Oncology. 17: 854-61. PMID 25586468 DOI: 10.1093/Neuonc/Nou348  1
2015 Sayour EJ, McLendon P, McLendon R, De Leon G, Reynolds R, Kresak J, Sampson JH, Mitchell DA. Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma. Cancer Immunology, Immunotherapy : Cii. 64: 419-27. PMID 25555571 DOI: 10.1007/S00262-014-1651-7  1
2015 Swartz AM, Batich KA, Fecci PE, Sampson JH. Peptide vaccines for the treatment of glioblastoma. Journal of Neuro-Oncology. 123: 433-40. PMID 25491947 DOI: 10.1007/s11060-014-1676-y  1
2015 Kirkpatrick JP, Wang Z, Sampson JH, McSherry F, Herndon JE, Allen KJ, Duffy E, Hoang JK, Chang Z, Yoo DS, Kelsey CR, Yin FF. Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial. International Journal of Radiation Oncology, Biology, Physics. 91: 100-8. PMID 25442342 DOI: 10.1016/J.Ijrobp.2014.09.004  1
2015 Mitchell DA, Sayour EJ, Reap E, Schmittling R, DeLeon G, Norberg P, Desjardins A, Friedman AH, Friedman HS, Archer G, Sampson JH. Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomide. Cancer Immunology Research. 3: 320-5. PMID 25387895 DOI: 10.1158/2326-6066.Cir-14-0100  1
2015 Batich KA, Swartz AM, Sampson JH. Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma. Expert Opinion On Biological Therapy. 15: 79-94. PMID 25327832 DOI: 10.1517/14712598.2015.972361  1
2015 Sampson JA, Fullagar HH, Gabbett T. Knowledge of bout duration influences pacing strategies during small-sided games. Journal of Sports Sciences. 33: 85-98. PMID 24904981 DOI: 10.1080/02640414.2014.925571  1
2015 Boyle J, McSherry F, Herndon J, Desjardins A, Sampson J, Peters K, Chino J, Allen K, Cabrera A, Kim G, Friedman H, Kirkpatrick J. Rtrb-04Stereotactic Radiosurgery For Recurrent High-Grade Gliomas: Patient Selection And The Role Of Bevacizumab Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov231.04  1
2015 Okada H, Weller M, Huang R, Finocchiaro G, Gilbert M, Wick W, Ellingson B, Hashimoto N, Pollack I, Brandes A, Franceschi E, Herold-Mende C, Nayak L, Panigrahy A, Pope W, ... Sampson J, et al. NIMG-56IMMUNOTHERAPY RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (iRANO): A REPORT OF THE RANO WORKING GROUP Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov225.56  1
2015 Omuro A, Baehring J, Sahebjam S, Vlahovic G, Voloschin A, Young R, Hayes W, Latek R, Coric V, Cloughesy T, Lim M, Sampson J, Reardon DA. NIMG-18EVALUATING TUMOR PROGRESSION AND IMMUNOLOGIC REACTIONS DURING IMMUNOTHERAPY: NEUROIMAGING OBSERVATIONS FROM A MULTICENTER STUDY OF NIVOLUMAB MONOTHERAPY AND NIVOLUMAB IN COMBINATION WITH IPILIMUMAB IN RECURRENT GLIOBLASTOMA (CHECKMATE-143) Neuro-Oncology. 17: v157.1-v157. DOI: 10.1093/Neuonc/Nov225.18  0.01
2015 Ramkissoon S, Sampson J, Vlahovic G, Sahebjam S, Omuro A, Baehring J, Latek R, Vandeloise E, Coric V, Cloughesy T, Lim M, Reardon D, Ligon K. NIMG-17CENTRAL NEUROPATHOLOGY REVIEW TO ASSIST IN THE EVALUATION OF IMMUNE-RELATED TREATMENT CHANGES VERSUS DISEASE PROGRESSION IN CHECKMATE-143 Neuro-Oncology. 17: v156.4-v157. DOI: 10.1093/Neuonc/Nov225.17  0.01
2015 Sahebjam S, Omuro A, Baehring J, Sampson J, Vlahovic G, Voloschin A, Hayes W, Latek R, Coric V, Cloughesy T, Lim M, Reardon DA. NIMG-16PSEUDOPROGRESSION AND IMMUNOTHERAPY IN GLIOBLASTOMA: A CASE SERIES FROM COHORT 1 OF CHECKMATE-143 (NCT02017717) Neuro-Oncology. 17: v156.3-v156. DOI: 10.1093/Neuonc/Nov225.16  0.01
2015 Sampson J, Omuro A, Vlahovic G, Sahebjam S, Baehring J, Hafler DA, Voloschin A, Simon J, Latek R, Coric V, Cloughesy T, Lim M, Reardon D. IMCT-03SAFETY AND ACTIVITY OF NIVOLUMAB MONOTHERAPY AND NIVOLUMAB IN COMBINATION WITH IPILIMUMAB IN RECURRENT GLIOBLASTOMA: UPDATED RESULTS FROM CHECKMATE-143 Neuro-Oncology. 17: v107.3-v107. DOI: 10.1093/Neuonc/Nov218.03  0.01
2015 Pham C, Flores C, Yang C, Sayour E, Pei Y, Moore C, McLendon R, Huang J, Sampson J, Wechsler-Reya R, Mitchell D. IMPS-25DIFFERENTIAL TUMOR MICROENVIRONMENTS AND RESPONSE TO IMMUNE CHECKPOINT BLOCKADE IN MOLECULAR SUBTYPES OF MURINE MEDULLOBLASTOMA Neuro-Oncology. 17: v118.3-v118. DOI: 10.1093/Neuonc/Nov217.24  0.01
2015 Lowther DE, Weinhold K, Reap E, Vlahovic G, Omuro A, Sahebjam S, Baehring J, Voloschin A, Cloughesy T, Lim M, Coric V, Latek R, Simon J, Lerner B, Raddassi K, ... Sampson J, et al. CBM-06IMMUNE BIOMARKER RESULTS FROM A TRIAL OF NIVOLUMAB ± IPILIMUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: CHECKMATE-143 Neuro-Oncology. 17: v70.2-v70. DOI: 10.1093/Neuonc/Nov211.06  0.01
2015 Weant M, Dunn-Pirio A, Peters K, Vlahovic G, Randazzo D, Herndon J, Healy P, Threatt S, Sampson J, Friedman A, Friedman H, Desjardins A. Atct-13Bevacizumab, Radiation Therapy (Rt) And Temozolomide Followed By Bevacizumab And Temozolomide With Continuation Of Bevacizumab Beyond Progression: A Phase Ii Trial Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov206.13  1
2014 Oh DS, Vredenburgh JA, Reardon DA, Prosnitz LR, Gockerman JP, Sampson JH, Kelsey CR, Kirkpatrick JP. Low-dose whole brain radiotherapy combined with radiosurgery for primary CNS lymphoma achieving partial response to induction methotrexate-based chemotherapy. Journal of Radiosurgery and Sbrt. 3: 37-42. PMID 29296383  1
2014 Johnson LA, Sanchez-Perez L, Suryadevara CM, Sampson JH. Chimeric antigen receptor engineered T cells can eliminate brain tumors and initiate long-term protection against recurrence. Oncoimmunology. 3: e944059. PMID 25610729 DOI: 10.4161/21624011.2014.944059  1
2014 Sanchez-Perez L, Suryadevara CM, Choi BD, Reap EA, Sampson JH. Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapy. Oncoimmunology. 3: e944054. PMID 25610727 DOI: 10.4161/21624011.2014.944054  1
2014 Fecci PE, Heimberger AB, Sampson JH. Immunotherapy for primary brain tumors: no longer a matter of privilege. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5620-9. PMID 25398845 DOI: 10.1158/1078-0432.CCR-14-0832  1
2014 Lin R, Chen L, Chen G, Hu C, Jiang S, Sevilla J, Wan Y, Sampson JH, Zhu B, Li QJ. Targeting miR-23a in CD8+ cytotoxic T lymphocytes prevents tumor-dependent immunosuppression. The Journal of Clinical Investigation. 124: 5352-67. PMID 25347474 DOI: 10.1172/Jci76561  1
2014 Congdon KL, Gedeon PC, Suryadevara CM, Caruso HG, Cooper LJ, Heimberger AB, Sampson JH. Epidermal growth factor receptor and variant III targeted immunotherapy. Neuro-Oncology. 16: viii20-5. PMID 25342601 DOI: 10.1093/Neuonc/Nou236  1
2014 Kirkpatrick JP, Sampson JH. Recurrent malignant gliomas. Seminars in Radiation Oncology. 24: 289-98. PMID 25219814 DOI: 10.1016/j.semradonc.2014.06.006  1
2014 Reardon DA, Freeman G, Wu C, Chiocca EA, Wucherpfennig KW, Wen PY, Fritsch EF, Curry WT, Sampson JH, Dranoff G. Immunotherapy advances for glioblastoma. Neuro-Oncology. 16: 1441-58. PMID 25190673 DOI: 10.1093/Neuonc/Nou212  1
2014 Swartz AM, Li QJ, Sampson JH. Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme. Immunotherapy. 6: 679-90. PMID 25186601 DOI: 10.2217/Imt.14.21  1
2014 Gedeon PC, Riccione KA, Fecci PE, Sampson JH. Antibody-based immunotherapy for malignant glioma. Seminars in Oncology. 41: 496-510. PMID 25173142 DOI: 10.1053/j.seminoncol.2014.06.004  1
2014 Batich KA, Sampson JH. Standard of care and future pharmacological treatment options for malignant glioma: an urgent need for screening and identification of novel tumor-specific antigens. Expert Opinion On Pharmacotherapy. 15: 2047-61. PMID 25139628 DOI: 10.1517/14656566.2014.947266  1
2014 Nair SK, Sampson JH, Mitchell DA. Immunological targeting of cytomegalovirus for glioblastoma therapy. Oncoimmunology. 3: e29289. PMID 25101224 DOI: 10.4161/onci.29289  1
2014 Kanaly CW, Mehta AI, Ding D, Hoang JK, Kranz PG, Herndon JE, Coan A, Crocker I, Waller AF, Friedman AH, Reardon DA, Sampson JH. A novel, reproducible, and objective method for volumetric magnetic resonance imaging assessment of enhancing glioblastoma. Journal of Neurosurgery. 121: 536-42. PMID 25036205 DOI: 10.3171/2014.4.JNS121952  1
2014 Collier BR, Holland L, McGhee D, Sampson JA, Bell A, Stapley PJ, Groeller H. Precision markedly attenuates repetitive lift capacity. Ergonomics. 57: 1427-39. PMID 25012299 DOI: 10.1080/00140139.2014.933885  1
2014 Brown MC, Dobrikova EY, Dobrikov MI, Walton RW, Gemberling SL, Nair SK, Desjardins A, Sampson JH, Friedman HS, Friedman AH, Tyler DS, Bigner DD, Gromeier M. Oncolytic polio virotherapy of cancer. Cancer. 120: 3277-86. PMID 24939611 DOI: 10.1002/Cncr.28862  1
2014 Babu R, Thomas S, Hazzard MA, Friedman AH, Sampson JH, Adamson C, Zomorodi AR, Haglund MM, Patil CG, Boakye M, Lad SP. Worse outcomes for patients undergoing brain tumor and cerebrovascular procedures following the ACGME resident duty-hour restrictions. Journal of Neurosurgery. 121: 262-76. PMID 24926647 DOI: 10.3171/2014.5.Jns1314  1
2014 Rosen MA, Lee BH, Sampson JB, Koka R, Chima AM, Ogbuagu OU, Marx MK, Kamara TB, Koroma M, Jackson EV. Failure mode and effects analysis applied to the maintenance and repair of anesthetic equipment in an austere medical environment. International Journal For Quality in Health Care : Journal of the International Society For Quality in Health Care / Isqua. 26: 404-10. PMID 24836514 DOI: 10.1093/Intqhc/Mzu053  1
2014 Choi BD, DeLong MR, Sampson JH. Response. Journal of Neurosurgery. 120: 728-9. PMID 24724172 DOI: 10.3171/2013.8.JNS131489  1
2014 Miao H, Choi BD, Suryadevara CM, Sanchez-Perez L, Yang S, De Leon G, Sayour EJ, McLendon R, Herndon JE, Healy P, Archer GE, Bigner DD, Johnson LA, Sampson JH. EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma. Plos One. 9: e94281. PMID 24722266 DOI: 10.1371/Journal.Pone.0094281  1
2014 Nair SK, De Leon G, Boczkowski D, Schmittling R, Xie W, Staats J, Liu R, Johnson LA, Weinhold K, Archer GE, Sampson JH, Mitchell DA. Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 2684-94. PMID 24658154 DOI: 10.1158/1078-0432.CCR-13-3268  1
2014 Sampson JH, Barker FG. Methodology and reporting of meta-analyses in the neurosurgical literature. Journal of Neurosurgery. 120: 791-4. PMID 24460491 DOI: 10.3171/2013.10.JNS13724  1
2014 Sampson JH, Vlahovic G. Editorial on "heat shock protein peptide complex-96 (HSPPC-96) vaccination for recurrent glioblastoma: a phase II, single arm trial". Neuro-Oncology. 16: 169-70. PMID 24443362 DOI: 10.1093/neuonc/not311  1
2014 Choi BD, DeLong MR, DeLong DM, Friedman AH, Sampson JH. Impact of PhD training on scholarship in a neurosurgical career. Journal of Neurosurgery. 120: 730-5. PMID 24359004 DOI: 10.3171/2013.11.JNS122370  1
2014 Sampson JH, Choi BD, Sanchez-Perez L, Suryadevara CM, Snyder DJ, Flores CT, Schmittling RJ, Nair SK, Reap EA, Norberg PK, Herndon JE, Kuan CT, Morgan RA, Rosenberg SA, Johnson LA. EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 972-84. PMID 24352643 DOI: 10.1158/1078-0432.CCR-13-0709  1
2014 Sampson JH, Lad SP, Herndon JE, Starke RM, Kondziolka D. SEER insights. Journal of Neurosurgery. 120: 297-8. PMID 24286150 DOI: 10.3171/2013.6.Jns13993  1
2014 Choi BD, Suryadevara CM, Gedeon PC, Herndon JE, Sanchez-Perez L, Bigner DD, Sampson JH. Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 21: 189-90. PMID 24054399 DOI: 10.1016/J.Jocn.2013.03.012  1
2014 Sampson JA, Donohoe A, Groeller H. Effect of concentric and eccentric velocity during heavy-load non-ballistic elbow flexion resistance exercise. Journal of Science and Medicine in Sport. 17: 306-11. PMID 23731958 DOI: 10.1016/j.jsams.2013.04.012  1
2014 Kang J, Desjardins A, Healy P, Herndon J, Lipp E, Peters K, Vlahovic G, Sampson J, Friedman H, Friedman A, Adamson C. Sm-02Levetiracetam Usage In Post-Operative Seizure Management In Malignant Glioma Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou277.2  1
2014 Mowery Y, Wright A, Desjardins A, Peters K, Ranjan T, Vlahovic G, Friedman H, Zomorodi A, Kaylie D, Adogwa O, Nimjee S, Sperduto W, Chagoya G, Fatemi P, McLendon R, ... Sampson J, et al. MS-19 * LONG-TERM OUTCOMES FOR PATIENTS WITH INTRACRANIAL MENINGIOMAS: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS Neuro-Oncology. 16: v130-v131. DOI: 10.1093/Neuonc/Nou260.18  0.01
2014 Flores C, Pham C, Snyder D, Yang S, Sanchez-Perez L, Sayour E, Cui X, Kemeny H, Friedman H, Bigner D, Sampson J, Mitchell D. IT-10 * SYNERGISTIC CELLULAR INTERACTIONS IN ADOPTIVE IMMUNOTHERAPY LEADS TO IMMUNOLOGIC REJECTION OF MALIGNANT GLIOMA Neuro-Oncology. 16: v111-v111. DOI: 10.1093/Neuonc/Nou258.8  0.01
2014 Vlahovic G, Archer G, Lally-Goss D, Reap E, Batich K, Desjardins A, Peters K, Ranjan T, Healy P, Herndon J, Friedman A, Friedman H, Bigner D, Sampson J. IT-34 * PILOT STUDY OF COMBINATION OF ANTITUMOR IMMUNOTHERAPY TARGETED AGAINST CYTOMEGALOVIRUS (CMV) PLUS REGULATORY T-CELL INHIBITION IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) Neuro-Oncology. 16: v117-v117. DOI: 10.1093/Neuonc/Nou258.32  0.01
2014 Reardon D, Schuster J, Tran D, Fink K, Nabors L, Li G, Lukas R, Desjardins A, Ashby L, Duic JP, Aneiro L, Hawthorne T, Green J, Yellin M, Davis T, Sampson J, et al. IT-30ReACT: A PHASE II STUDY OF RINDOPEPIMUT VACCINE (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou258.28  1
2014 Kirkpatrick J, Wang Z, Sampson J, McSherry F, Herndon J, Allen K, Duffy E, Chang Z, Hoang J, Kelsey C, Yoo D, Cabrera A, Yin F. Bm-17Final Results Of A Randomized Trial To Identify The Optimal Planning Target Volume In Image-Guided Stereotactic Radiosurgery Of Brain Metastases Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou240.17  1
2014 Ghiaseddin A, Dunn-Pirio A, Peters K, Vlahovic G, Herndon J, Threatt S, Sampson J, Friedman A, Friedman H, Desjardins A. At-22Phase Ii Trial Of Bevacizumab, Radiation Therapy (Rt) And Temozolomide Followed By Bevacizumab And Temozolomide With Continuation Of Bevacizumab Beyond Progression Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou237.22  1
2014 Desjardins A, Sampson J, Peters K, Vlahovic G, Threatt S, Herndon J, Boulton S, Lally-Goss D, McSherry F, Lipp E, Friedman A, Friedman H, Bigner D, Gromeier M. AT-21 * FINAL RESULTS OF A PHASE 1 TRIAL OF AN ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) AGAINST RECURRENT GLIOBLASTOMA (GBM) Neuro-Oncology. 16: v13-v13. DOI: 10.1093/Neuonc/Nou237.21  0.01
2014 Desjardins A, Herndon J, McSherry F, Ravelo A, Lipp E, Healy P, Peters K, Vlahovic G, Sampson J, Friedman A, Friedman H. At-20Single Institution Retrospective Review Of Performance Status And Corticosteroid Use In Newly Diagnosed Glioblastoma (Gbm) Patients (Pts) Treated On Bevacizumab (Bev) Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou237.20  1
2014 Desjardins A, Herndon J, McSherry F, Ravelo A, Lipp E, Healy P, Boulton S, Peters K, Vlahovic G, Sampson J, Friedman A, Friedman H. At-19Single Institution Retrospective Comparison Of Glioblastoma (Gbm) Patients (Pts) Initiated On Bevacizumab (Bev) Before Versus After Recurrence In Clinical Practice Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou237.19  1
2014 Gromeier M, Dobrikova E, Dobrikov M, Brown M, Bryant J, Threatt S, Boulton S, Carter K, Herndon J, Desjardins A, Friedman H, Sampson J, Friedman A, Bigner D. ONCOLYTIC POLIOVIRUS IMMUNOTHERAPY OF GLIOBLASTOMA Neuro-Oncology. 16: iii41-iii41. DOI: 10.1093/Neuonc/Nou208.69  0.01
2014 Sampson J, Mitchell DA, Batich KA, Snyder D, Xie W, Reap E, Cui X, Sanchez-Perez L, Archer GE, Nair SK, Gunn MD. RANDOMIZATION OF PATIENTS WITH GLIOBLASTOMA TO VACCINE SITE PRE-CONDITIONING WITH TETANUS-DIPHTHERIA TOXOID SYSTEMICALLY ENHANCES MIGRATION AND THERAPEUTIC EFFECT OF CYTOMEGALOVIRUS PP65-PULSED DENDRITIC CELL VACCINE IN A MIP-1α-DEPENDENT FASHION Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou208.63  1
2013 Choi BD, Gedeon PC, Herndon JE, Archer GE, Reap EA, Sanchez-Perez L, Mitchell DA, Bigner DD, Sampson JH. Human regulatory T cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibody. Cancer Immunology Research. 1: 163. PMID 24570975 DOI: 10.1158/2326-6066.Cir-13-0049  1
2013 Choi BD, Gedeon PC, Sanchez-Perez L, Bigner DD, Sampson JH. Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibody. Oncoimmunology. 2: e26757. PMID 24475376 DOI: 10.4161/Onci.26757  1
2013 Congdon KL, Sampson JH. Enhanced oncolytic virotherapy through oxidative stress inhibition. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1981-3. PMID 24201213 DOI: 10.1038/Mt.2013.227  1
2013 Yang S, Archer GE, Flores CE, Mitchell DA, Sampson JH. A cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model. Cancer Immunology, Immunotherapy : Cii. 62: 1649-62. PMID 23982483 DOI: 10.1007/s00262-013-1464-0  1
2013 Dannull J, Haley NR, Archer G, Nair S, Boczkowski D, Harper M, De Rosa N, Pickett N, Mosca PJ, Burchette J, Selim MA, Mitchell DA, Sampson J, Tyler DS, Pruitt SK. Melanoma immunotherapy using mature DCs expressing the constitutive proteasome. The Journal of Clinical Investigation. 123: 3135-45. PMID 23934126 DOI: 10.1172/Jci67544  1
2013 Gedeon PC, Choi BD, Hodges TR, Mitchell DA, Bigner DD, Sampson JH. An EGFRvIII-targeted bispecific T-cell engager overcomes limitations of the standard of care for glioblastoma. Expert Review of Clinical Pharmacology. 6: 375-86. PMID 23927666 DOI: 10.1586/17512433.2013.811806  1
2013 Chandramohan V, Mitchell DA, Johnson LA, Sampson JH, Bigner DD. Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors. Future Oncology (London, England). 9: 977-90. PMID 23837761 DOI: 10.2217/Fon.13.47  1
2013 Choi BD, Gedeon PC, Kuan CT, Sanchez-Perez L, Archer GE, Bigner DD, Sampson JH. Rational design and generation of recombinant control reagents for bispecific antibodies through CDR mutagenesis. Journal of Immunological Methods. 395: 14-20. PMID 23806556 DOI: 10.1016/J.Jim.2013.06.003  1
2013 Batich KA, William St Clair E, McLendon RE, Sampson JH. Complete response to steroids in dural inflammatory pseudotumor associated with Still's disease. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 20: 1445-8. PMID 23768965 DOI: 10.1016/J.Jocn.2013.01.009  1
2013 Reardon DA, Wucherpfennig KW, Freeman G, Wu CJ, Chiocca EA, Wen PY, Curry WT, Mitchell DA, Fecci PE, Sampson JH, Dranoff G. An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma. Expert Review of Vaccines. 12: 597-615. PMID 23750791 DOI: 10.1586/Erv.13.41  1
2013 Choi BD, Pastan I, Bigner DD, Sampson JH. A novel bispecific antibody recruits T cells to eradicate tumors in the "immunologically privileged" central nervous system. Oncoimmunology. 2: e23639. PMID 23734318 DOI: 10.4161/Onci.23639  1
2013 Cabrera AR, Cuneo KC, Desjardins A, Sampson JH, McSherry F, Herndon JE, Peters KB, Allen K, Hoang JK, Chang Z, Craciunescu O, Vredenburgh JJ, Friedman HS, Kirkpatrick JP. Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial. International Journal of Radiation Oncology, Biology, Physics. 86: 873-9. PMID 23725997 DOI: 10.1016/J.Ijrobp.2013.04.029  1
2013 Babu R, Hatef J, McLendon RE, Cummings TJ, Sampson JH, Friedman AH, Adamson C. Clinicopathological characteristics and treatment of rhabdoid glioblastoma. Journal of Neurosurgery. 119: 412-9. PMID 23641829 DOI: 10.3171/2013.3.Jns121773  1
2013 Mehta AI, Babu R, Sharma R, Karikari IO, Grunch BH, Owens TR, Agarwal VJ, Sampson JH, Lad SP, Friedman AH, Kuchibhatla M, Bagley CA, Gottfried ON. Thickness of subcutaneous fat as a risk factor for infection in cervical spine fusion surgery. The Journal of Bone and Joint Surgery. American Volume. 95: 323-8. PMID 23426766 DOI: 10.2106/Jbjs.L.00225  1
2013 Nonaka Y, Fukushima T, Watanabe K, Friedman AH, Sampson JH, Mcelveen JT, Cunningham CD, Zomorodi AR. Contemporary surgical management of vestibular schwannomas: analysis of complications and lessons learned over the past decade. Neurosurgery. 72: ons103-15; discussio. PMID 23037828 DOI: 10.1227/NEU.0b013e3182752b05  1
2013 Ambady P, Holdhoff M, Ferrigno C, Grossman S, Anderson MD, Liu D, Conrad C, Penas-Prado M, Gilbert MR, Yung AWK, Groot Jd, Aoki T, Nishikawa R, Sugiyama K, Nonoguchi N, ... Sampson J, et al. Neuro/Medical Oncology Neuro-Oncology. 15: 120-120. DOI: 10.1093/Neuonc/Not182  1
2013 Campian J, Gladstone D, Ambady P, Ye X, King K, Borrello I, Petrik S, Golightly M, Holdhoff M, Grossman S, Bhardwaj R, Chakravadhanula M, Ozols V, Georges J, Carlson E, ... Sampson J, ... Sampson J, ... Sampson J, ... Sampson J, et al. IMMUNOTHERAPY/BIOLOGICAL THERAPIES Neuro-Oncology. 15: iii68-iii74. DOI: 10.1093/Neuonc/Not178  0.01
2013 Zomorodi A, Nonaka Y, Friedman A, Sampson J, Fukushima T. Surgical Management of Vestibular Schwannomas after Failed Radiation Skull Base Surgery. 74. DOI: 10.1055/S-0033-1336256  1
2013 Kirkpatrick JP, Wang Z, Sampson J, Kelsey C, Allen K, Duffy E, Green S, Cabrera A, Palta M, Yin F. Early Results of a Randomized Trial to Identify an Optimal PTV in Stereotactic Radiosurgery of Brain Metastases International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.131  1
2012 Choi BD, Mehta AI, Batich KA, Friedman AH, Sampson JH. The use of motor mapping to aid resection of eloquent gliomas. Neurosurgery Clinics of North America. 23: 215-25, vii. PMID 22440865 DOI: 10.1016/j.nec.2012.01.013  1
2012 Sampson JH, Schmittling RJ, Archer GE, Congdon KL, Nair SK, Reap EA, Desjardins A, Friedman AH, Friedman HS, Herndon JE, Coan A, McLendon RE, Reardon DA, Vredenburgh JJ, Bigner DD, et al. A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma. Plos One. 7: e31046. PMID 22383993 DOI: 10.1371/Journal.Pone.0031046  1
2012 Mehta AI, Choi BD, Ajay D, Raghavan R, Brady M, Friedman AH, Pastan I, Bigner DD, Sampson JH. Convection enhanced delivery of macromolecules for brain tumors. Current Drug Discovery Technologies. 9: 305-10. PMID 22339074 DOI: 10.2174/157016312803305951  1
2012 Reardon DA, Desjardins A, Peters KB, Gururangan S, Sampson JH, McLendon RE, Herndon JE, Bulusu A, Threatt S, Friedman AH, Vredenburgh JJ, Friedman HS. Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma. Journal of Neuro-Oncology. 107: 155-64. PMID 21986722 DOI: 10.1007/S11060-011-0722-2  1
2012 Vredenburgh JJ, Desjardins A, Kirkpatrick JP, Reardon DA, Peters KB, Herndon JE, Marcello J, Bailey L, Threatt S, Sampson J, Friedman A, Friedman HS. Addition of bevacizumab to standard radiation therapy and daily temozolomide is associated with minimal toxicity in newly diagnosed glioblastoma multiforme. International Journal of Radiation Oncology, Biology, Physics. 82: 58-66. PMID 21036490 DOI: 10.1016/J.Ijrobp.2010.08.058  1
2012 Dannull J, Haley NR, Archer G, Nair S, Rosa ND, Selim M, Tyler DS, Sampson J, Pruitt SK. Abstract 5373: Altering the composition of the proteasome of melanoma antigen RNA-transfected dendritic cells enhances vaccination-induced anti-melanoma immunity: results of a Phase I trial Cancer Research. 72: 5373-5373. DOI: 10.1158/1538-7445.Am2012-5373  1
2012 Pollack IF, Jakacki RI, Butterfield L, Okada H, Chiba Y, Hashimoto N, Kagawa N, Kinoshita M, Kijima N, Hirayama R, Oji Y, Tsuboi A, Oka Y, Sugiyama H, Yoshimine T, ... Sampson JH, ... Sampson J, ... Sampson JH, ... Sampson J, et al. CLIN-IMMUNOTHERAPY/BIOLOGIC THERAPIES Neuro-Oncology. 14: vi43-vi49. DOI: 10.1093/Neuonc/Nos224  0.04
2012 Fujita M, Zhang R, Nakata S, Kuzushima K, Wainwright DA, Balyasnikova IV, Auffinger B, Ahmed AU, Han Y, Lesniak MS, Knight A, Arnouk H, Gillespie GY, Britt W, Su Y, ... Sampson JH, ... Sampson JH, ... Sampson JH, ... Sampson JH, ... Sampson J, et al. LAB-IMMUNOLOGY RESEARCH Neuro-Oncology. 14: vi38-vi42. DOI: 10.1093/Neuonc/Nos223  0.01
2012 Lewis S, Vredenburgh J, Desjardins A, Peters K, Green S, Hood R, Yang Y, Sampson J, Wang Z, Kirkpatrick JP. Patterns of Failure as a Function of Clinical Target Volumes in Patients With GBM Treated With Radiation Therapy (RT), Temozolomide, and Bevacizumab International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.694  1
2012 Cuneo KC, Vredenburgh J, Desjardins A, Peters K, Sampson J, Allen K, Chang Z, Duffy E, Peterson B, Kirkpatrick JP. Impact of Concurrent and Adjuvant Bevacizumab on the Risk of Radiation Necrosis Following Radiosurgery for Recurrent Glioma International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.024  1
2011 Mehta AI, Choi BD, Raghavan R, Brady M, Friedman AH, Bigner DD, Pastan I, Sampson JH. Imaging of convection enhanced delivery of toxins in humans. Toxins. 3: 201-6. PMID 22069706 DOI: 10.3390/Toxins3030201  1
2011 Mehta AI, Kanaly CW, Friedman AH, Bigner DD, Sampson JH. Monitoring radiographic brain tumor progression. Toxins. 3: 191-200. PMID 22069705 DOI: 10.3390/Toxins3030191  1
2011 Mitchell DA, Cui X, Schmittling RJ, Sanchez-Perez L, Snyder DJ, Congdon KL, Archer GE, Desjardins A, Friedman AH, Friedman HS, Herndon JE, McLendon RE, Reardon DA, Vredenburgh JJ, Bigner DD, Sampson JH, et al. Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans. Blood. 118: 3003-12. PMID 21768296 DOI: 10.1182/Blood-2011-02-334565  1
2011 Sampson JH, Raghavan R, Brady M, Friedman AH, Bigner D. Convection-enhanced delivery. Journal of Neurosurgery. 115: 463-4; discussion 46. PMID 21619413 DOI: 10.3171/2010.11.Jns101801  1
2011 Reardon DA, Desjardins A, Peters KB, Vredenburgh JJ, Gururangan S, Sampson JH, McLendon RE, Herndon JE, Coan A, Threatt S, Friedman AH, Friedman HS. Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy. Cancer. 117: 5351-8. PMID 21590689 DOI: 10.1002/Cncr.26188  1
2011 Vredenburgh JJ, Desjardins A, Reardon DA, Peters KB, Herndon JE, Marcello J, Kirkpatrick JP, Sampson JH, Bailey L, Threatt S, Friedman AH, Bigner DD, Friedman HS. The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 4119-24. PMID 21531816 DOI: 10.1158/1078-0432.Ccr-11-0120  1
2011 Sampson JH, Herndon JE, Friedman AH, Abernethy AP. Epidemiology. Journal of Neurosurgery. 115: 256-7; discussion 25. PMID 21529133 DOI: 10.3171/2011.1.JNS102066  1
2011 Reardon DA, Turner S, Peters KB, Desjardins A, Gururangan S, Sampson JH, McLendon RE, Herndon JE, Jones LW, Kirkpatrick JP, Friedman AH, Vredenburgh JJ, Bigner DD, Friedman HS. A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma. Journal of the National Comprehensive Cancer Network : Jnccn. 9: 414-27. PMID 21464146 DOI: 10.6004/Jnccn.2011.0038  1
2011 Sampson JH, Brady M, Raghavan R, Mehta AI, Friedman AH, Reardon DA, Petry NA, Barboriak DP, Wong TZ, Zalutsky MR, Lally-Goss D, Bigner DD. Colocalization of gadolinium-diethylene triamine pentaacetic acid with high-molecular-weight molecules after intracerebral convection-enhanced delivery in humans. Neurosurgery. 69: 668-76. PMID 21430586 DOI: 10.1227/Neu.0B013E3182181Ba8  1
2011 Leon GD, Mitchell D, Sampson J. A promising cancer vaccine Future Oncology. 7: 331-334. PMID 21417898 DOI: 10.2217/Fon.11.17  1
2011 Kanaly CW, Ding D, Mehta AI, Waller AF, Crocker I, Desjardins A, Reardon DA, Friedman AH, Bigner DD, Sampson JH. A novel method for volumetric MRI response assessment of enhancing brain tumors. Plos One. 6: e16031. PMID 21298088 DOI: 10.1371/Journal.Pone.0016031  1
2011 Sampson JH, Aldape KD, Archer GE, Coan A, Desjardins A, Friedman AH, Friedman HS, Gilbert MR, Herndon JE, McLendon RE, Mitchell DA, Reardon DA, Sawaya R, Schmittling R, Shi W, et al. Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma. Neuro-Oncology. 13: 324-33. PMID 21149254 DOI: 10.1093/Neuonc/Noq157  1
2011 Reardon DA, Desjardins A, Peters K, Gururangan S, Sampson J, Rich JN, McLendon R, Herndon JE, Marcello J, Threatt S, Friedman AH, Vredenburgh JJ, Friedman HS. Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy. Journal of Neuro-Oncology. 103: 371-9. PMID 20853132 DOI: 10.1007/S11060-010-0403-6  1
2011 Cuneo KC, Cabrera AR, Sampson J, Allen K, Duffy E, Vredenburgh JJ, Peters KB, Chang Z, Desjardins A, Kirkpatrick JP. Concurrent bevacizumab and radiosurgery for recurrent malignant glioma: toxicity results from a prospective pilot study F1000research. 2. DOI: 10.7490/F1000Research.1089492.1  1
2011 Cuneo KC, Cabrera AR, Sampson J, Allen K, Duffy E, Vredenburgh JJ, Peters KB, Chang Z, Desjardins A, Kirkpatrick JP. Bevacizumab and Radiosurgery for Recurrent Malignant Glioma: Toxicity Results from a Prospective Pilot Study International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.330  1
2011 Wang Z, Yin F, Chang Z, Sampson J, Kirkpatrick JP. Imaging-Guided Localization for Stereotactic Radiosurgery of Multiple Intracranial Lesions with a Single Isocenter Setup International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.1530  1
2010 Sampson JH, Heimberger AB, Archer GE, Aldape KD, Friedman AH, Friedman HS, Gilbert MR, Herndon JE, McLendon RE, Mitchell DA, Reardon DA, Sawaya R, Schmittling RJ, Shi W, Vredenburgh JJ, et al. Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 4722-9. PMID 20921459 DOI: 10.1200/Jco.2010.28.6963  1
2010 Kunwar S, Chang S, Westphal M, Vogelbaum M, Sampson J, Barnett G, Shaffrey M, Ram Z, Piepmeier J, Prados M, Croteau D, Pedain C, Leland P, Husain SR, Joshi BH, et al. Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro-Oncology. 12: 871-81. PMID 20511192 DOI: 10.1093/Neuonc/Nop054  1
2010 Oh DS, Reardon DA, Prosnitz LR, Gockerman JP, Sampson J, Kirkpatrick JP. Low-dose Whole Brain Radiotherapy followed by Radiosurgery for Primary CNS Lymphoma Achieving Partial Response to Induction Chemotherapy International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.696  1
2008 Desjardins A, Reardon DA, Herndon JE, Marcello J, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Sampson J, Bailey L, Bigner DD, Friedman AH, Friedman HS, Vredenburgh JJ. Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 7068-73. PMID 18981004 DOI: 10.1158/1078-0432.Ccr-08-0260  1
2008 Varenika V, Dickinson P, Bringas J, LeCouteur R, Higgins R, Park J, Fiandaca M, Berger M, Sampson J, Bankiewicz K. Detection of infusate leakage in the brain using real-time imaging of convection-enhanced delivery. Journal of Neurosurgery. 109: 874-80. PMID 18976077 DOI: 10.3171/Jns/2008/109/11/0874  1
2008 Selznick LA, Shamji MF, Fecci P, Gromeier M, Friedman AH, Sampson J. Molecular strategies for the treatment of malignant glioma--genes, viruses, and vaccines. Neurosurgical Review. 31: 141-55; discussion 1. PMID 18259789 DOI: 10.1007/S10143-008-0121-0  1
2007 Vredenburgh JJ, Desjardins A, Herndon JE, Marcello J, Reardon DA, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Sampson J, Wagner M, Bailey L, Bigner DD, Friedman AH, Friedman HS. Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 4722-9. PMID 17947719 DOI: 10.1200/Jco.2007.12.2440  1
Show low-probability matches.